C6orf10
low-frequency variants
multiple sclerosis
rare variants
whole exome sequencing
Journal
Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621
Informations de publication
Date de publication:
2019
2019
Historique:
received:
30
10
2018
accepted:
31
05
2019
entrez:
13
7
2019
pubmed:
13
7
2019
medline:
13
7
2019
Statut:
epublish
Résumé
In light of the complex nature of multiple sclerosis (MS) and the recently estimated contribution of low-frequency variants into disease, decoding its genetic risk components requires novel variant prioritization strategies. We selected, by reviewing MS Genome Wide Association Studies (GWAS), 107 candidate loci marked by intragenic single nucleotide polymorphisms (SNPs) with a remarkable association (
Identifiants
pubmed: 31297130
doi: 10.3389/fgene.2019.00573
pmc: PMC6607989
doi:
Types de publication
Journal Article
Langues
eng
Pagination
573Références
Genome Res. 2005 Mar;15(3):436-42
pubmed: 15741513
J Immunol. 2009 Feb 1;182(3):1541-7
pubmed: 19155502
Mult Scler. 2011 May;17(5):634-6
pubmed: 21239413
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Leuk Res. 2012 Apr;36(4):474-8
pubmed: 22071137
Ann Neurol. 2011 Dec;70(6):881-6
pubmed: 22190362
Neurology. 2012 Jul 31;79(5):406-11
pubmed: 22744673
BMC Med Genet. 2012 Aug 10;13:70
pubmed: 22883388
Nature. 2013 Jan 24;493(7433):561-4
pubmed: 23222540
Ann Neurol. 2013 Mar;73(3):430-2
pubmed: 23444327
Mult Scler. 2014 Oct;20(12):1564-8
pubmed: 24740369
Lancet Neurol. 2014 Aug;13(8):807-22
pubmed: 25008549
Front Genet. 2015 Feb 24;6:66
pubmed: 25759719
Immunity. 2015 Apr 21;42(4):613-26
pubmed: 25862091
J Autoimmun. 2015 Nov;64:13-25
pubmed: 26142251
Hum Genet. 2015 Nov;134(11-12):1143-62
pubmed: 26407970
Neuroepidemiology. 2016;46(1):37-42
pubmed: 26618996
Front Immunol. 2015 Dec 24;6:647
pubmed: 26734011
Neuron. 2016 Jun 1;90(5):948-54
pubmed: 27253448
Mol Ther Nucleic Acids. 2016 Oct 4;5(10):e370
pubmed: 27701399
Neuron. 2016 Oct 19;92(2):333-335
pubmed: 27764667
Neuron. 2016 Oct 19;92(2):336-338
pubmed: 27764668
Nat Rev Neurol. 2017 Jan;13(1):25-36
pubmed: 27934854
Neurol Sci. 2017 Mar;38(3):473-479
pubmed: 28040843
Clin Immunol. 2017 Jul;180:100-105
pubmed: 28501589
Sci Rep. 2017 Jun 16;7(1):3715
pubmed: 28623311
Biomol Concepts. 2017 Sep 26;8(3-4):197-202
pubmed: 28753533
Oncotarget. 2017 May 22;8(34):56802-56815
pubmed: 28915632
Immunogenetics. 2018 Mar;70(3):205-207
pubmed: 28988323
BMC Res Notes. 2017 Dec 12;10(1):735
pubmed: 29233175
Cold Spring Harb Perspect Med. 2018 Jul 2;8(7):
pubmed: 29440325
Immunol Invest. 2018 Jul;47(5):431-442
pubmed: 29648897
Cold Spring Harb Perspect Med. 2019 May 1;9(5):null
pubmed: 29661806
Front Neurol. 2018 Apr 20;9:245
pubmed: 29731736
Mult Scler. 2019 Jun;25(7):909-917
pubmed: 29873607
Immunohorizons. 2017 Aug 1;1(6):109-123
pubmed: 30035254
Neuroepidemiology. 2018;51(3-4):158-165
pubmed: 30130759
Mol Med. 2018 Aug 9;24(1):42
pubmed: 30134823
Brain. 2018 Oct 1;141(10):2895-2907
pubmed: 30252044
Cell. 2018 Nov 29;175(6):1679-1687.e7
pubmed: 30343897
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237